These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33807220)

  • 1. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review.
    Timmer FEF; Geboers B; Nieuwenhuizen S; Schouten EAC; Dijkstra M; de Vries JJJ; van den Tol MP; Meijerink MR; Scheffer HJ
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of locoregional therapy for metastatic pancreatic ductal adenocarcinoma to the liver: a single-center experience.
    Bailey RE; Surapaneni PK; Core J; Vidal LLC; LeGout J; Ritchie C; Frey G; McKinney JM; Sella D; Paz-Fumagalli R; Toskich B; Mody K
    J Gastrointest Oncol; 2019 Aug; 10(4):688-694. PubMed ID: 31392049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
    Ghidini M; Petrillo A; Salati M; Khakoo S; Varricchio A; Tomasello G; Grossi F; Petrelli F
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31374916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis.
    Rochefort P; Lardy-Cleaud A; Sarabi M; Desseigne F; Cattey-Javouhey A; de la Fouchardière C
    Oncologist; 2019 Dec; 24(12):1543-1548. PubMed ID: 31164454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
    Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic Disease in Pancreatic Cancer - How to Proceed?
    Renz BW; Boeck S; Roeder F; Trumm C; Heinemann V; Werner J
    Visc Med; 2017 Mar; 33(1):36-41. PubMed ID: 28612015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma.
    Gao J; Wang J; Guan C; Shi W; Dong Q; Sheng J; Zou X; Xu Z; Ge Y; Huang Z; Li J; Bao H; Xu Y; Cui Y; Xu X; Zhong X
    J Cancer; 2024; 15(8):2214-2228. PubMed ID: 38495490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis by site of primary tumor of patients with unresectable locally-advanced or metastatic pancreatic adenocarcinoma receiving chemotherapy.
    Colloca GA; Venturino A; Guarneri D
    Clin Exp Metastasis; 2019 Dec; 36(6):519-525. PubMed ID: 31578654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
    Hank T; Klaiber U; Hinz U; Schütte D; Leonhardt CS; Bergmann F; Hackert T; Jäger D; Büchler MW; Strobel O
    Ann Surg; 2023 May; 277(5):e1089-e1098. PubMed ID: 35758505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.
    Hong Y; Rice J; Sharma D; Martin RCG
    Am J Surg; 2018 Jul; 216(1):106-110. PubMed ID: 29506753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels.
    Kälsch J; Padden J; Bertram S; Pott LL; Reis H; Westerwick D; Schaefer CM; Sowa JP; Möllmann D; Fingas C; Dechȇne A; Sitek B; Eisenacher M; Canbay A; Ahrens M; Baba HA
    Virchows Arch; 2017 May; 470(5):537-543. PubMed ID: 28357490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?
    Frigerio I; Regi P; Giardino A; Scopelliti F; Girelli R; Bassi C; Gobbo S; Martini PT; Capelli P; D'Onofrio M; Malleo G; Maggino L; Viviani E; Butturini G
    Ann Surg Oncol; 2017 Aug; 24(8):2397-2403. PubMed ID: 28516291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review.
    Halle-Smith JM; Powell-Brett S; Roberts K; Chatzizacharias NA
    World J Gastrointest Surg; 2023 Jul; 15(7):1512-1521. PubMed ID: 37555114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.
    Abendroth A; Noureddine R; Abramczyk M; Paul A; Gerken G; Schmid KW; Markus P; Schumacher B; Wiesweg M; Köhler J; Markus M; Mende B; Dechêne A; Schuler M; Kasper S
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):445-455. PubMed ID: 30430229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature.
    Sakaguchi T; Valente R; Tanaka K; Satoi S; Del Chiaro M
    Pancreatology; 2019 Jul; 19(5):672-680. PubMed ID: 31285145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.
    Delpero JR; Sauvanet A
    Front Oncol; 2020; 10():40. PubMed ID: 32117714
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.